Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H13FN4O2 |
Molecular Weight | 360.3412 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(F)C=C4
InChI
InChIKey=BGIYKDUASORTBB-UHFFFAOYSA-N
InChI=1S/C20H13FN4O2/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(8-4-15)25(26)27/h1-12H,(H,23,24)
Molecular Formula | C20H13FN4O2 |
Molecular Weight | 360.3412 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14521923Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22913737
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14521923
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22913737
PD-169316 is a selective inhibitor of p38 MAPK. It inhibits p38 MAPK with an IC50 of 89 nM. PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells. In an amyloid β (Aβ) rat model of Alzheimer's disease it was demonstrated that caspase-3 and Bax/Bcl-2 ratio, two marks of apoptosis, were significantly decreased in the rats pre-treated with PD169316 intracerebroventricularly.This study suggested the potential neuroprotective role of PD 169316 against the neuronal toxicity induced by Aβ.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. | 2004 Mar |
|
Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. | 2007 Jan |
|
15-Deoxy-Delta-Prostaglandin J(2) Upregulates the Expression of LPS-Induced IL-8/CXCL8 mRNA in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats. | 2009 Apr |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22913737
Rats: ICV infusion of PD169316 (30 ug/5ml 1% DMSO in PBS) with PBS injection (3 ul/side in CA1)
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14521923
Pretreatment of CaOV3 cells with 10 uM PD-169316 resulted in
decreased TGFb1-induced Smad2 and Smad3 phosphorylation
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:09:02 GMT 2023
by
admin
on
Sat Dec 16 08:09:02 GMT 2023
|
Record UNII |
GX3Y2V80CV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
GX3Y2V80CV
Created by
admin on Sat Dec 16 08:09:02 GMT 2023 , Edited by admin on Sat Dec 16 08:09:02 GMT 2023
|
PRIMARY | |||
|
4712
Created by
admin on Sat Dec 16 08:09:02 GMT 2023 , Edited by admin on Sat Dec 16 08:09:02 GMT 2023
|
PRIMARY | |||
|
DTXSID8042684
Created by
admin on Sat Dec 16 08:09:02 GMT 2023 , Edited by admin on Sat Dec 16 08:09:02 GMT 2023
|
PRIMARY | |||
|
152121-53-4
Created by
admin on Sat Dec 16 08:09:02 GMT 2023 , Edited by admin on Sat Dec 16 08:09:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |